Home / Inspections / 1079946

FDA Inspection 1079946 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 3016799712

The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on December 20, 2018 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 20, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)

Facility

Other inspections at this facility

  • 1274952 (NAI Wed Jul 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1233201 (NAI Wed Dec 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010958 (NAI Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources